Erald Shehu

The expression and function of human Anterior Gradient Homolog 3 in Prostate Cancer

Erald Shehu, 2013 .

Investigating the phosphinic acid tripeptide mimetic DG013A as a tool compound inhibitor of the M1-aminopeptidase ERAP1

R. V. van Montfort, F. Raynaud, A. Hayes, 2021, Bioorganic & medicinal chemistry letters.

Discovering cell-active BCL6 inhibitors: effectively combining biochemical HTS with multiple biophysical techniques, X-ray crystallography and cell-based assays

O. Rossanese, Benjamin R Bellenie, R. V. van Montfort, 2022, Scientific Reports.

Differences in wild-type– and R338L-tenase complex formation are at the root of R338L-factor IX assay discrepancies

I. Yu, R. Corbau, S. Kitchen, 2022, Blood advances.

Anterior gradient 2 and 3 – two prototype androgen‐responsive genes transcriptionally upregulated by androgens and by oestrogens in prostate cancer cells

H. Klocker, C. Fuchsberger, B. Timmermann, 2013, The FEBS journal.

Achieving In Vivo Target Depletion through the Discovery and Optimization of Benzimidazolone BCL6 Degraders

O. Rossanese, Benjamin R Bellenie, R. V. van Montfort, 2020, Journal of medicinal chemistry.

C8-substituted pyrido[3,4-d]pyrimidin-4(3H)-ones: Studies towards the identification of potent, cell penetrant Jumonji C domain containing histone lysine demethylase 4 subfamily (KDM4) inhibitors, compound profiling in cell-based target engagement assays

G. F. Ruda, O. Fedorov, O. Rossanese, 2019, European journal of medicinal chemistry.